drugset / Trial / NCT02739516

Dual FSH/HCG Trigger in Letrozole Stimulated Intrauterine Insemination Cycles in Women With Unexplained Infertility

NCT02739516

Phase 3 Completed 108 enrolled Benha University
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study was to evaluate the outcome of follicle stimulating hormone (FSH) co-administration with human chorionic gonadotrophins trigger for women with unexplained infertility (UEI) and assigned for letrozole (LTZ) stimulated intrauterine insemination (IUI) cycles .

Timeline

Start
2014-06
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bravelle Unknown 150 iu Intramuscular
Background Letrozole Other / unclassified 2.5 mg Oral
Background human chorionic gonadotropin Protein / enzyme biologic 10000 iu Intramuscular

Indications